| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | BUY | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.11▲ | 2.11▲ | 2.11▲ | 2.14▼ | 2.01▲ |
| MA10 | 2.13▲ | 2.14▼ | 2.14▲ | 2.04▲ | 2.03▲ |
| MA20 | 2.13▲ | 2.13▲ | 2.15▼ | 2.01▲ | 2.21▼ |
| MA50 | 2.16▼ | 2.15▼ | 2.08▲ | 2.05▲ | 2.09▲ |
| MA100 | 2.19▼ | 2.07▲ | 2.08▲ | 2.21▼ | 2.50▼ |
| MA200 | 2.10▲ | 2.15▼ | 2.22▼ | 2.09▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | -0.004▼ | -0.010▼ | 0.028▲ | -0.015▼ |
| RSI | 50.718▲ | 49.207▼ | 50.445▲ | 55.128▲ | 50.224▲ |
| STOCH | 41.964 | 41.667 | 41.667 | 52.405 | 19.425▼ |
| WILL %R | -43.750 | -43.750 | -43.750 | -52.941 | -68.966 |
| CCI | -25.097 | -2.498 | -1.131 | 61.332 | -2.774 |
| CDL | $BCG Hammer Candlestick Pattern Detected | Set Alert |
|
Friday, May 08, 2026 04:05 PM
enGene (NASDAQ:ENGN) reported preliminary data from the pivotal Cohort 1 of its ongoing Phase 2 LEGEND trial evaluating detalimogene voroplasmide, or detalimogene, in patients with high-risk ...
|
|
Tuesday, May 05, 2026 04:31 AM
( NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced it will present new treatment comparison results evaluating ANKTIVA ® (nogapendekin alfa inbakicept-pmln) plus Bacillus ...
|
|
Monday, April 27, 2026 03:04 PM
Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage biotechnology company developing transformative therapies for the treatment of cancer and rare diseases, today announced that updated, inter ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/05/26 | 2.12 | 2.14 | 2.05 | 2.14 | 131,041 |
| 08/05/26 | 2.14 | 2.21 | 2.076 | 2.14 | 109,616 |
| 07/05/26 | 2.125 | 2.20 | 2.0764 | 2.08 | 116,960 |
| 06/05/26 | 2.43 | 2.50 | 2.06 | 2.13 | 472,353 |
| 05/05/26 | 2.03 | 2.38 | 1.99 | 2.22 | 264,951 |
| 04/05/26 | 1.96 | 2.0599 | 1.92 | 2.00 | 43,972 |
| 01/05/26 | 2.00 | 2.0799 | 1.90 | 1.92 | 36,762 |
| 30/04/26 | 1.89 | 2.09 | 1.8503 | 1.99 | 185,472 |
| 29/04/26 | 1.85 | 1.9185 | 1.84 | 1.86 | 8,721 |
| 28/04/26 | 1.82 | 1.92 | 1.82 | 1.92 | 36,320 |
|
|
||||
|
|
||||
|
|